Hiroyuki Yamazaki

Dr. Hiroyuki Yamazaki

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
PDF file
HYHiroyuki Yamazaki
Hiroyuki Yamazaki
YTYukiharu Todo
Yukiharu Todo
CSChisa Shimada
Chisa Shimada
STSho Takeshita
Sho Takeshita
SMShinichiro Minobe
Shinichiro Minobe
HKHidenori Kato
Hidenori Kato
Yamazaki H, et al. J Gynecol Oncol. 2017 Dec;29:e19. https://doi.org/10.3802/jgo.2018.29.e19

22 March 2019 in Heart and Vessels
Verified
Journal Article
Closed access
PDF file
TKToshiki Kuno
Toshiki Kuno
KHKeita Hirano
Keita Hirano
TATakayuki Abe
Takayuki Abe
SIShohei Imaeda
Shohei Imaeda
KHKenji Hashimoto
Kenji Hashimoto
YNYohei Numasawa
Yohei Numasawa

13 July 2022 in Cancer Science
Verified
Journal Article
Open access
HYHiroyuki Yamazaki
Hiroyuki Yamazaki
HAHiroshi Asano
Hiroshi Asano
KHKanako C. Hatanaka
Kanako C. Hatanaka
RMRyosuke Matsuoka
Ryosuke Matsuoka
YKYosuke Konno
Yosuke Konno
HWHidemichi Watari
Hidemichi Watari
This study aimed to validate the Proactive Molecular Risk Classifier for Endometrial Cancer, a modified version of The Cancer Genome Atlas, using data from 184 patients with endometrial cancer (median age: 57.5 years; median follow‐up period: 109 months) who had undergone radical surgery (including systemic lymphadenectomy) and subsequent adjuvant chemotherapy (patients with intermediate or high recurrence risk) from 2003 to 2015. Tissue microarrays were prepared from surgical specimens and classified using the conventional clinical risk classifier. Immunohistochemistry was used to detect mismatch repair proteins, L1 cell adhesion molecule, and p53. Direct sequencing was used to identify hotspot mutations in the polymerase‐epsilon gene. Forty‐five patients were identified as having high L1 cell adhesion molecule expression, 41 as low risk, 34 as mismatch repair‐deficient, 13 as polymerase‐epsilon gene‐mutated, five as having abnormal p53, and 46 as other. Patients were stratified into significantly different prognostic groups (p < 0.0001): favorable (low risk and polymerase‐epsilon gene‐mutated), intermediate (mismatch repair‐deficient and other), and unfavorable (high L1 cell adhesion molecule expression and abnormal p53) with 5‐year disease‐specific survival rates of 100%, 93.8%, and 75.1%, respectively (Kaplan–Meier method). The combination of conventional recurrent risk classification, sequencing for polymerase‐epsilon gene mutations and immunohistochemistry for L1 cell adhesion molecule, p53, and mismatch repair proteins can be used to determine the prognoses of patients with endometrial cancer.

1 January 2016 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
HMHiroko Matsumiya
Hiroko Matsumiya
YTYukiharu Todo
Yukiharu Todo
KOKazuhira Okamoto
Kazuhira Okamoto
STSho Takeshita
Sho Takeshita
HYHiroyuki Yamazaki
Hiroyuki Yamazaki
HKHidenori Kato
Hidenori Kato
Matsumiya H, et al. J Gynecol Oncol. 2016 May;27:e55. http://dx.doi.org/10.3802/jgo.2016.27.e55

8 September 2023 in Cancer Science
Verified
Journal Article
Open access
MOMamiko Onuki
Mamiko Onuki
FTFumiaki Takahashi
Fumiaki Takahashi
TITakashi Iwata
Takashi Iwata
HNHiroshi Nakazawa
Hiroshi Nakazawa
HYHideaki Yahata
Hideaki Yahata
FGfor the MINT Study Group
for the MINT Study Group
The first prophylactic vaccine against human papillomavirus (HPV) 16 and HPV18 was licensed in Japan in 2009. HPV vaccine effectiveness against high-grade cervical lesions has been demonstrated among young Japanese women, but evidence of its effects on invasive cervical cancer (ICC) is lacking. Using data from two different cancer registries, we compared recent trends of new ICC cases by age group using Poisson regression analysis. We also analyzed time trends in HPV16/18 prevalence among 1414 Japanese women aged <40 years newly diagnosed with ICC in the past decade. Based on the population-based cancer registry, the incidence of ICC among young women aged 20-29 years showed a significant decline from 3.6 to 2.8 per 100 000 women-years during 2016-2019, but no similar decline was observed for older age groups (p < 0.01). Similarly, using data from the gynecological cancer registry of the Japan Society of Obstetrics and Gynecology, the annual number of ICCs among women aged 20-29 years also decreased from 256 cases to 135 cases during 2011-2020 (p < 0.0001). Furthermore, a declining trend in HPV16/18 prevalence in ICC was observed only among women aged 20-29 years during 2017-2022 (90.5%-64.7%, p = 0.05; Cochran-Armitage trend test). This is the first report to suggest population-level effects of HPV vaccination on ICC in Japan. Although the declining trend in HPV16/18 prevalence among young women with ICC supports a causal linkage between vaccination and results from cancer registries, further studies are warranted to confirm that our findings are attributable to vaccination.

12 December 2017 in Biomedical Optics Express
Verified
Journal Article
Open access
PDF file
DSDaisuke Sakota
Daisuke Sakota
TFTatsuki Fujiwara
Tatsuki Fujiwara
KOKatsuhiro Ohuchi
Katsuhiro Ohuchi
KKKatsuyuki Kuwana
Katsuyuki Kuwana
HYHiroyuki Yamazaki
Hiroyuki Yamazaki
OMOsamu Maruyama
Osamu Maruyama
We developed an optical thrombus sensor for a monopivot extracorporeal centrifugal blood pump. In this study, we investigated its quantitative performance for thrombus detection in acute animal experiments of left ventricular assist using the pump on pathogen-free pigs. Optical fibers were set in the driver unit of the pump. The incident light at the near-infrared wavelength of 810 nm was aimed at the pivot bearing, and the resulting scattered light was guided to the optical fibers. The detected signal was analyzed to obtain the thrombus formation level. As a result, real-time and quantitative monitoring of the thrombus surface area on the pivot bearing was achieved with an accuracy of 3.6 ± 2.3 mm2. In addition, the sensing method using the near-infrared light was not influenced by changes in the oxygen saturation and the hematocrit. It is expected that the developed sensor will be useful for optimal anticoagulation management for long-term extracorporeal circulation therapies.